Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dmitry Galkin
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
Omalizumab Treatment in Brittle Asthma
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology
Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria
Bőrgyógyászati és Venerológiai Szemle
Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?
Italian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
